Company

Braveheart Bio

https://www.braveheart.bio/

Industryclinical-stage biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy (HCM) and related conditions

Funding raised

CompanyRoundDate
Braveheart BioSeries A2025-11-05